EHJ Editor-in-Chief
@ehj_ed
Followers
38K
Following
701
Media
3K
Statuses
3K
Official twitter account of the European Heart Journal Editor-in-Chief. Tweets by Prof. Filippo Crea and his team. #EHJ.
Rome, Italy
Joined January 2020
EHJ issue 46 - 45 is online: https://t.co/dwiglZ5wuL Explore the mechanisms and novel therapeutic targets of atherothrombosis. @escardio @ESC_Journals #EHJ #cardiotwitter
1
3
13
Imidazole Propionate: A Novel Cardiovascular Risk Indicator in Patients with Coronary Artery Disease! Read the news in #EHJ! #EHJ #cardiotwitter #gut #microbiota #cardiovascular #risk
@ESC_journals @escardio
https://t.co/dd96bmIZdu
1
6
19
Power your home for less. Generate clean energy from the sun and save every month with Tesla Solar.
0
107
565
Frailty and long-term outcomes in younger patients with acute myocardial infarction. Read more in the @EHJ at https://t.co/zgO3vNa1HO
#AcuteMyocardialInfarction #Frailty #LongTermOutcomes @ESCardio @ESC_journals
1
18
57
Underweight and cardiovascular risk in Type 2 diabetes: a Korean nationwide study. Read more in the @EHJ at https://t.co/M9o9fk7eTY
#Type2Diabetes #KoreanStudy #UnderweightRisks @ESCardio @ESC_Journals
1
9
38
Women with chronic coronary artery disease: long-term outcomes after percutaneous coronary intervention vs coronary artery bypass grafting. Read more in the @EHJ at https://t.co/Rmaz3xwKsv
#WomenInMedicine #PercutaneousCoronaryIntervention #CoronaryArteryDisease @ESCardio
1
11
31
EHJ Dialogue with Prof. Hugo Katus on the past, present, and future of troponins
2
2
13
MSc in Clinical Trials – Applications open In collaboration with the University of Oxford, this part-time distance learning programme offers rigorous training in the design and conduct of randomised clinical trials. With two short residential periods in Oxford, the course is
0
38
131
Cardiac fibroblasts in myocardial injury and heart failure. Read this interesting review in the @EHJ at https://t.co/nV8pPnxmZq
#MyocardialInjury #Fibroblasts #CardiacHealth @ESCardio @ESC_Journals
0
24
55
Atherosclerosis is a chronic inflammatory disease of the arterial wall. New study reveals that enhanced antigen presentation by macrophages activates local T-cell inflammatory response. https://t.co/n9iJ46ObqE
#atherosclerosis #inflammation #cardiotwitter, @ESC_Journals,
1
30
73
Atherosclerosis is a chronic inflammatory disease of the arterial wall. New study reveals that enhanced antigen presentation by macrophages activates local T-cell inflammatory response. https://t.co/n9iJ46ObqE
#atherosclerosis #inflammation #cardiotwitter, @ESC_Journals,
5
29
84
Advances in imaging and hardware technologies created the opportunity for clinical visualization of molecules and cells that underpin atherosclerosis pathobiology. Read the new state of the art review! https://t.co/h7EOHmq1TR
#imaging #CardtoCT #OCT #cardiotwitter, @ESC_Journals,
1
11
29
Coronary revascularization: a long-term perspective. A state of the art review just published in the @EHJ at https://t.co/ry52o7XeiZ
#CoronaryRevascularization #HeartHealth #CardiacCare #HeartSurgery @ESCardio @ESC_Journals
2
33
113
A must-read paper in #EHJ! Coronary revascularization: a long-term perspective. A State-of-the-Art review forecasting advancements by 2040, drawing on historical trends and recent breakthroughs. @escardio @ESC_Journals #CardioTwitter
https://t.co/2I8oeozR6s
5
104
259
EHJ issue 46 - 44 is online: https://t.co/ioWFmEe6UP Delve into the Guidelines for the management of valvular heart disease and learn about novel studies identifying Lp(a) as an important therapeutic target. @escardio @ESC_Journals #EHJ #cardiotwitter
0
5
16
Cardiac endogenous transmitter system: molecular features, functions, and clinical implications. Read this State-of-the-Art review in #EHJ
@escardio @ESC_Journals #CardioTwitter
https://t.co/TSerGM89e4
0
5
24
Optical coherence tomography-guided stent optimization for complex coronary lesions. Read the results of the OCCUPI trial in #EHJ
@escardio @ESC_Journals #OCT #PCI #CardioTwitter
https://t.co/IhRayl0CPH
1
10
31
Automated patch clamp data improve variant classification and penetrance stratification for SCN5A–Brugada syndrome. Read more in #EHJ
@escardio @ESC_Journals #Brugadasyndrome
https://t.co/C3hC9JkZc4
1
6
20
Over the past two decades, the risk of stroke in atrial fibrillation patients decreased significantly among all age groups, with no subsequent increase in the risk of bleeding. Read more in #EHJ
@escardio @ESC_Journals #atrialfibrillation
https://t.co/rAhd2bBlTH
1
14
53
Atherosclerosis is a chronic inflammatory disease of the arterial wall. New study reveals that enhanced antigen presentation by macrophages activates local T-cell inflammatory response. https://t.co/n9iJ46ObqE
#atherosclerosis #inflammation #cardiotwitter, @ESC_Journals,
1
23
65
Peri-procedural management of epicardial ventricular arrhythmias ablation: 2025 clinical consensus developed collaboratively by European Heart Rhythm Association (EHRA), the Heart Rhythm Society (HRS), the Asia Pacific Heart Rhythm Society (APHRS), the Latin American Heart Rhythm
1
9
15